Cartesian Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisNCT06799247Decartes-08Active not recruiting2026-12-30Estimated

Phase 2 5 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 100 participants (planned). After: 128 participants (actual).

Primary completion date changed

Before: 30 Nov 2026. After: 30 Dec 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source
Descartes-08 in Autoantibody Myositis

NCT07391605 · Cartesian Therapeutics

· 2 fields changed

Primary completion date changed

Before: Nov 2026. After: Nov 2027.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 30 participants (planned). After: 6 participants (actual).

Primary completion date changed

Before: 1 Nov 2025. After: 1 Dec 2025.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source